Author:
Nilsson Lennart J.,Regnström Karin J.
Reference17 articles.
1. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research Washington D.C. Preliminary guidelines for the manufacture and evaluation of DNA vaccines. (1996) Docket 96N–0400.
2. Pilaro, A.M., and Serabian, M.A. (1999) Preclinical development strategies for novel gene therapeutic products. Toxicol. Pathol.
27, 4–7.
3. Fauci, A.S. (2001) Infectious diseases: considerations for the 21st century. Clin. Infect. Dis.
32, 675–685.
4. Pauwels, R., van der Straeten, M., Platteau, B., and Bazin, H. (1983) The non-specific enhancement of allergy. In vivo effects of Bordetella pertussis vaccine on IgE synthesis. Allergy. 38, 239–246.
5. Dhiman, N., Bornilla, R., O'Kane, D.J., and Poland, G.A. (2001) Gene expression microarrays: a 21st century tool for directed vaccine design. Vaccine.
20, 22–30.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献